Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (47)

« Back to Publications

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Noronha IH. et al, (2026), J Infect Dis

Advances in Alphavirus and Flavivirus Research II.

Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Dold C. et al, (2026), Mol Ther

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Paganotti Vicentine M. et al, (2026), BMJ Open, 16

Eight-Year Vaccine Protection Following a Single Dose of VI-Tetanus Toxoid Conjugate Vaccine in Nepali Children: Extended Follow-Up of the TyVAC Nepal Randomised Controlled Trial

Pant D. et al, (2026)

Impact of Dosing Interval on Immunogenicity Following a Heterologous Typhoid Conjugate Vaccine Booster in Nepalese Children: An Observational Study

Zhang Y. et al, (2026)

Persistence of Immune Responses 5 Years After Vaccination With a Single Dose of Typhoid Conjugate Vaccine (TCV) in Nepalese Children

Pant D. et al, (2026)

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

McCann N. et al, (2025), N Engl J Med, 393, 1704 - 1714

Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2025), PLoS Negl Trop Dis, 19

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.

Kim YC. and Reyes-Sandoval A., (2025), Vaccines (Basel), 13

Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Kim YC. et al, (2025), NPJ Vaccines, 10

Heterologous prime-boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models.

De Lorenzo G. et al, (2025), Front Immunol, 16

Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Kim YC. et al, (2024), NPJ Vaccines, 9

5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.

Qadri F. et al, (2024), Lancet, 404, 1419 - 1429

Mayaro Virus: An Emerging Alphavirus in the Americas.

Wei LLL. et al, (2024), Viruses, 16

Load More